These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 18821746)
21. Development of a Ligand Screening Tool Using Full-Length Human Peroxisome Proliferator-Activated Receptor-Expressing Cell Lines to Ameliorate Metabolic Syndrome. Tachibana K; Ishimoto K; Takahashi R; Kadono H; Awaji T; Yuzuriha T; Tanaka T; Hamakubo T; Sakai J; Kodama T; Aoki S; Doi T Chem Pharm Bull (Tokyo); 2019; 67(3):199-202. PubMed ID: 30827999 [TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype. Kuwabara N; Oyama T; Tomioka D; Ohashi M; Yanagisawa J; Shimizu T; Miyachi H J Med Chem; 2012 Jan; 55(2):893-902. PubMed ID: 22185225 [TBL] [Abstract][Full Text] [Related]
23. Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated Receptors. Miyachi H Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502131 [TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivity. Motoshima K; Ishikawa M; Hashimoto Y; Sugita K Bioorg Med Chem; 2011 May; 19(10):3156-72. PubMed ID: 21514830 [TBL] [Abstract][Full Text] [Related]
27. The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development. Hong F; Xu P; Zhai Y Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060458 [TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Giaginis C; Tsantili-Kakoulidou A; Theocharis S Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292 [TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptors target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis. Pirard B J Comput Aided Mol Des; 2003 Nov; 17(11):785-96. PubMed ID: 15072437 [TBL] [Abstract][Full Text] [Related]
31. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis. Hummasti S; Tontonoz P Mol Endocrinol; 2006 Jun; 20(6):1261-75. PubMed ID: 16556736 [TBL] [Abstract][Full Text] [Related]
32. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands. Seimandi M; Lemaire G; Pillon A; Perrin A; Carlavan I; Voegel JJ; Vignon F; Nicolas JC; Balaguer P Anal Biochem; 2005 Sep; 344(1):8-15. PubMed ID: 16038868 [TBL] [Abstract][Full Text] [Related]
34. Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists. Maltarollo VG; Togashi M; Nascimento AS; Honorio KM PLoS One; 2015; 10(3):e0118790. PubMed ID: 25767888 [TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptors and the metabolic syndrome. Bragt MC; Popeijus HE Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967 [TBL] [Abstract][Full Text] [Related]
38. The need for physiologically relevant peroxisome proliferator-activated receptor-gamma (PPAR-γ) ligands. Subramani PA; Reddy MC; Narala VR Endocr Metab Immune Disord Drug Targets; 2013 Jun; 13(2):175-83. PubMed ID: 23713695 [TBL] [Abstract][Full Text] [Related]
39. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Takacs ML; Abbott BD Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030 [TBL] [Abstract][Full Text] [Related]
40. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]